Clinical characteristics and PTPN22 1858CT variant analysis in jordanian arab vitiligo patients

Molecular Diagnosis and Therapy

Volumn 14, Issue 3, 2010, Pages 179-184

  Alkhateeb, Asem ^a   Qarqaz, Firas ^a   Al Sabah, Jude ^a   Al Rashaideh, Tasnim ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

1858C>T; PTPN22; single nucleotide polymorphisms; Vitiligo

Indexed keywords

DNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; ARAB; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOMOZYGOTE; HUMAN; INTERVIEW; JORDAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITILIGO;

ADULT; ALLELES; ARABS; FEMALE; HUMANS; JORDAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; VITILIGO; YOUNG ADULT;

EID: 77954109368     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03256371     Document Type: Article

References (50)

1. Boissy RE, Spritz RA. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol 2009; 18 (7): 583-585
2. Howitz J, Brodthagen H, Schwartz M, et al. Prevalence of vitiligo; epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113 (1): 47-52
3. Sun X, Xu A, Wei X, et al. Genetic epidemiology of vitiligo: a study of 815 probands and their families from South China. Int J Dermatol 2006; 45 (10): 1176-1181
4. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16 (3): 208-214
5. LaBerge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005; 18 (4): 300-305
6. Blomhoff A, Kemp EH, Gawkrodger DJ, et al. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 2005; 18 (1): 55-58
7. Birlea SA, LaBerge GS, Procopciuc LM, et al. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res 2009; 22 (2): 230-234
8. Retornaz G, Betuel H, Ortonne JP, et al. HL-A antigens and vitiligo. Br J Dermatol 1976; 95 (2): 173-175
9. Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 227-243
10. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356 (12): 1216-1225
11. Jin Y, Birlea SA, Fain PR, et al. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007; 127 (11): 2558-2562
12. Canton I, Askhatar S, Gavalas NG, et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosinase phosphatase PTPN22 confers susceptibility to generalized vitiligo. Genes Immun 2005; 6 (7): 584-587
13. Laddha NC, Dwivedi M, Shajil EM, et al. Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population. J Dermatol Sci 2007; 49 (3): 260-262
14. LaBerge GS, Bennett DC, Fain PR, et al. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 2008; 128 (7): 1757-1762
15. LaBerge GS, Birlea SA, Fain PR, et al. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Pigment Cell Melanoma Res 2008; 21: 206-208
16. Spritz RA. The genetics of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 244-257
17. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189 (1): 111-121
18. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36 (4): 337-338
19. Velaga MR, Wilson V, Jennings CE, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004; 89 (11): 5862-5865
20. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75 (2): 330-337
21. Kyogoku C, Langefeld CD, Ortmann WA, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75 (3): 504-507
22. Vandiedonck C, Capdevielle C, Giraud M, et al. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 2006; 59 (2): 404-407
23. Skinningsrud B, Husebye ES, Gervin K, et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008; 16 (8): 977-982
24. Taieb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35
25. Rozen S, Skaletsky H. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386
26. Freeman GH, Halton JH.Note on exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951; 38: 141-149
27. Alzolibani A. Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta Dermatovenerol Alp Panonica Adriat 2009; 18 (3): 119-125
28. Arý can O, KoçK, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Panonica Adriat 2008; 17 (3): 129-132
29. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561-571
30. Arechiga AF, Habib T, He Y, et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009; 182 (6): 3343-3347
31. Douroudis K, Prans E, Haller K, et al. Protein tyrosine phosphatase nonreceptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 2008; 72 (5): 425-430
32. Korolija M, Renar IP, Hadzija M, et al. Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians. Diabetes Res Clin Pract 2009; 86 (3): e54-7
33. Roycroft M, Fichna M, McDonald D, et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxf) 2009; 70 (3): 358-362
34. Steck AK, Liu SY, McFann K, et al. Association of the PTPN22/LYP gene with type 1 diabetes. Pediatr Diabetes 2006; 7 (5): 274-278
35. Farago B, Talian GC, Komlosi K, et al. Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 2009; 29 (7): 793-796
36. Harrison P, Pointon JJ, Farrar C, et al. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2006; 45 (8): 1009-1011
37. Santin I, Castellanos-Rubio A, Aransay AM, et al. The functional R620W variant of the PTPN22 gene is associated with celiac disease. Tissue Antigens 2008; 71 (3): 247-249
38. Bravo MJ, Colmenero JD, Queipo-Ortuño MI, et al. PTPN22 C1858T polymorphism and human brucellosis. Scand J Infect Dis 2009; 41 (2): 109-112
39. Milkiewicz P, Pache I, Buwaneswaran H, et al. The PTPN22 1858T variant is not associated with primary biliary cirrhosis. Tissue Antigens 2006; 67 (5): 434-437
40. van Oene M, Wintle RF, Liu X, et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005; 52 (7): 1993-1998
41. Wesoly J, Hu X, Thabet MM, et al. The 620W allele is the PTPN22 genetic variant conferring susceptibility toRAin a Dutch population. Rheumatology (Oxford) 2007; 46 (4): 617-621
42. Dultz G, Matheis N, Dittmar M, et al. The protein tyrosine phosphatase nonreceptor type 22 C1858T polymorphism is a joint susceptibility locus for immune thyroiditis and autoimmune diabetes. Thyroid 2009; 19 (2): 143-148
43. Gomez LM, Anaya JM, Gonzalez CI, et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 2005; 6 (7): 628-631
44. Lamsyah H, Rueda B, Baassi L, et al. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens 2009; 74 (3): 228-232
45. Chabchoub G, Teixiera EP, Maalej A, et al. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol 2009; 36 (3): 342-349
46. Sahin N, Aksu K, Kamali S, et al. PTPN22 gene polymorphism in Takayasu's arteritis. Rheumatology (Oxford) 2008; 47 (5): 634-635
47. Ray D, Tomar N, Gupta N, et al. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene R620W variant and sporadic idiopathic hypoparathyroidism in Asian Indians. Int J Immunogenet 2006; 33 (4): 237-240
48. Zhang ZH, Chen F, Zhang XL, et al. PTPN22 allele polymorphisms in 15 Chinese populations. Int J Immunogenet 2008; 35 (6): 433-437
49. Ichimura M, Kaku H, Fukutani T, et al. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility toGraves' disease in a Japanese population. Thyroid 2008; 18 (6): 625-630
50. Baranathan V, Stanford MR, Vaughan RW, et al. The association of the PTPN22 620W polymorphism with Behcet's disease.Ann Rheum Dis 2007; 66 (11): 1531-1533